
Mission BioCapital invests in early‑stage life‑science and biotechnology companies, providing capital, lab space, drug‑discovery services and strategic mentorship. The firm focuses on high‑potential biomedical innovations that can benefit from a combined offering of funding, shared laboratory infrastructure, and access to a network of industry partners.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
EuropeUnited States
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United States of America
60.3%United Kingdom
13.8%Philippines
3.4%Switzerland
1.7%Japan
1.7%Other
1.7%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
Pre-Seed → Series B
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Mission BioCapital V LP
Vintage 2021 • $275M
Mission BioCapital VI LP
Vintage 2025 • $143.8M
Check sizes
Typical: $500K
Max: $500K